| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 129.46B | 131.38B | 128.14B | 125.74B | 123.50B | 109.92B |
| Gross Profit | 24.69B | 25.61B | 24.32B | 21.88B | 20.35B | 18.92B |
| EBITDA | 15.13B | 11.41B | 16.42B | 15.35B | 11.73B | 10.23B |
| Net Income | 6.98B | 7.57B | 7.37B | 6.88B | 4.56B | 3.94B |
Balance Sheet | ||||||
| Total Assets | 114.53B | 119.10B | 116.47B | 115.65B | 112.00B | 102.64B |
| Cash, Cash Equivalents and Short-Term Investments | 23.43B | 26.55B | 24.47B | 21.88B | 23.48B | 20.70B |
| Total Debt | 12.06B | 8.36B | 11.80B | 10.15B | 10.58B | 9.86B |
| Total Liabilities | 41.59B | 40.66B | 40.69B | 41.63B | 39.84B | 37.19B |
| Stockholders Equity | 63.41B | 67.62B | 64.87B | 64.44B | 63.20B | 57.76B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.56B | 7.25B | 6.50B | 4.54B | 1.84B |
| Operating Cash Flow | 0.00 | 13.40B | 11.55B | 10.75B | 8.52B | 4.57B |
| Investing Cash Flow | 0.00 | -2.15B | -3.15B | -1.67B | -3.96B | -2.44B |
| Financing Cash Flow | 0.00 | -9.29B | -6.51B | -11.12B | -2.34B | -2.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥40.41B | 5.95 | ― | 0.13% | 7.87% | 43.57% | |
76 Outperform | ¥45.32B | 5.81 | ― | 3.53% | -5.41% | 31.52% | |
74 Outperform | ¥83.52B | 12.60 | ― | 3.06% | 2.53% | 5.98% | |
71 Outperform | ¥119.77B | 17.82 | ― | 0.67% | 5.45% | -7.61% | |
67 Neutral | ¥102.32B | 10.01 | ― | 3.88% | -3.89% | -3.31% | |
64 Neutral | ¥29.99B | 6.94 | ― | 3.53% | 4.47% | 9.89% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |